E Darracott Vaughan. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » 5-alpha Reductase InhibitorsAdrenergic alpha-Antagonists/therapeutic useDisease ProgressionDrug Therapy, CombinationEnzyme Inhibitors/therapeutic useFinasteride/therapeutic useHumansMaleProstatic Hyperplasia/classificationProstatic Hyperplasia/drug therapySeverity of Illness Index
Substances: See more » 5-alpha Reductase InhibitorsAdrenergic alpha-AntagonistsEnzyme InhibitorsFinasteride
Year: 2003 PMID: 14681512 DOI: 10.1056/NEJMe038154
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245